Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino
GeriPal
MARCH 9, 2023
Today we largely focus on reasons for caution, including: We know almost nothing about psychedelics in older adults – only about 1% of patients in published trials were older adults, much less older adults with multiple chronic conditions, multiple medications, and frailty. There is a marked lack of diversity in published trials.
91 
Let's personalize your content